171 related articles for article (PubMed ID: 28782557)
1. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.
Lu J; Li X; Wang F; Guo Y; Huang Y; Zhu H; Wang Y; Lu Y; Wang Z
Exp Cell Res; 2017 Oct; 359(2):319-326. PubMed ID: 28782557
[TBL] [Abstract][Full Text] [Related]
2. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
3. [Expression of miR-216a in pancreatic cancer and its clinical significance].
Hou B; Jian Z; Chen S; Ou Y; Li S; Ou J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1628-31. PubMed ID: 23174591
[TBL] [Abstract][Full Text] [Related]
4. miR-216a may inhibit pancreatic tumor growth by targeting JAK2.
Hou BH; Jian ZX; Cui P; Li SJ; Tian RQ; Ou JR
FEBS Lett; 2015 Aug; 589(17):2224-32. PubMed ID: 26149212
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Wang S; Chen X; Tang M
Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
8. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer.
Li J; Kong F; Wu K; Song K; He J; Sun W
Mol Med Rep; 2014 Nov; 10(5):2613-20. PubMed ID: 25215905
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
Chen Q; Wang P; Fu Y; Liu X; Xu W; Wei J; Gao W; Jiang K; Wu J; Miao Y
Oncol Rep; 2017 Dec; 38(6):3567-3573. PubMed ID: 29039566
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.
Xu S; Wang T; Song W; Jiang T; Zhang F; Yin Y; Jiang SW; Wu K; Yu Z; Wang C; Chen K
Sci Rep; 2015 Aug; 5():13528. PubMed ID: 26314494
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis.
Wang W; Wang J; Yang C; Wang J
IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells.
Liu M; Du Y; Gao J; Liu J; Kong X; Gong Y; Li Z; Wu H; Chen H
Pancreas; 2013 Oct; 42(7):1169-81. PubMed ID: 24048456
[TBL] [Abstract][Full Text] [Related]
13. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
15. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
16. YB-1 promotes laryngeal squamous cell carcinoma progression by inducing miR-155 expression via c-Myb.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(16):1579-1589. PubMed ID: 29517281
[TBL] [Abstract][Full Text] [Related]
17. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
Wang J; Wang B; Ren H; Chen W
Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy.
Zhang X; Shi H; Lin S; Ba M; Cui S
Oncol Rep; 2015 Sep; 34(3):1557-64. PubMed ID: 26134156
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer.
Cai H; Yao J; An Y; Chen X; Chen W; Wu D; Luo B; Yang Y; Jiang Y; Sun D; He X
Oncotarget; 2017 May; 8(20):32905-32917. PubMed ID: 28415631
[TBL] [Abstract][Full Text] [Related]
20. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
